Metformin impairs the growth of liver kinase B1-intact cervical cancer cells

Gynecologic Oncology

Volumn 127, Issue 1, 2012, Pages 249-255

  Xiao, Xuxian ^a   He, Qiongqiong ^a   Lu, Changming ^a   Werle, Kaitlin D ^a   Zhao, Rui Xun ^a   Chen, Jianfeng ^a   Davis, Ben C ^a   Cui, Rutao ^b   Liang, Jiyong ^c   Xu, Zhi Xiang ^a  

^a University of Alabama at Birmingham   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

AMPK; Cervical cancer; LKB1; Metformin

Indexed keywords

LIVER KINASE B1 PROTEIN; METFORMIN; PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER INHIBITION; DRUG SENSITIVITY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UTERINE CERVIX CANCER;

AMP-ACTIVATED PROTEIN KINASES; APOPTOSIS; AUTOPHAGY; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; HELA CELLS; HUMANS; METFORMIN; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; UTERINE CERVICAL NEOPLASMS;

EID: 84865685190     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.06.032     Document Type: Article

References (61)

1. D. Saslow, P.E. Castle, J.T. Cox, D.D. Davey, M.H. Einstein, and D.G. Ferris American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors CA Cancer J Clin 57 1 2007 7 28
2. M. Steben, and E. Duarte-Franco Human papillomavirus infection: epidemiology and pathophysiology Gynecol Oncol 107 2007 S2 S5
3. H.J. Long III Management of metastatic cervical cancer: review of the literature J Clin Oncol 25 20 2007 2966 2974
4. S.E. Moody, J.S. Boehm, D.A. Barbie, and W.C. Hahn Functional genomics and cancer drug target discovery Curr Opin Mol Ther 12 3 2010 284 293
5. J.I. Risinger, G.L. Maxwell, G.V. Chandramouli, O. Aprelikova, T. Litzi, and A. Umar Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling Cancer Res 65 12 2005 5031 5037
6. A. Hemminki, D. Markie, I. Tomlinson, E. Avizienyte, S. Roth, and A. Loukola A serine/threonine kinase gene defective in Peutz-Jeghers syndrome Nature 391 1998 184 187
7. D.B. Shackelford, and R.J. Shaw The LKB1-AMPK pathway: metabolism and growth control in tumour suppression Nat Rev Cancer 9 8 2009 563 575
8. D.R. Alessi, K. Sakamoto, and J.R. Bayascas LKB1-dependent signaling pathways Annu Rev Biochem 75 2006 137 163
9. H. Cheng, P. Liu, Z.C. Wang, L. Zou, S. Santiago, and V. Garbitt SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis Sci Signal 2 80 2009 ra35
10. H. Ji, M.R. Ramsey, D.N. Hayes, C. Fan, K. McNamara, and P. Kozlowski LKB1 modulates lung cancer differentiation and metastasis Nature 448 2007 807 810
11. D. Zhong, L. Guo, I. de Aguirre, X. Liu, N. Lamb, and S.Y. Sun LKB1 mutation in large cell carcinoma of the lung Lung Cancer 53 3 2006 285 294
12. S.N. Wingo, T.D. Gallardo, E.A. Akbay, M.C. Liang, C.M. Contreras, and T. Boren Somatic LKB1 mutations promote cervical cancer progression PLoS One 4 4 2009 e5137
13. M.T. McCabe, D.R. Powell, W. Zhou, and P.M. Vertino Homozygous deletion of the STK11/LKB1 locus and the generation of novel fusion transcripts in cervical cancer cells Cancer Genet Cytogenet 197 2 2010 130 141
14. N. Bardeesy, M. Sinha, A.F. Hezel, S. Signoretti, N.A. Hathaway, and N.E. Sharpless Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation Nature 419 2002 162 167
15. J. Carretero, T. Shimamura, K. Rikova, A.L. Jackson, M.D. Wilkerson, and C.L. Borgman Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors Cancer Cell 17 6 2010 547 559
16. B. Gan, J. Hu, S. Jiang, Y. Liu, E. Sahin, and L. Zhuang Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells Nature 468 7324 2010 701 704
17. S. Gurumurthy, S.Z. Xie, B. Alagesan, J. Kim, R.Z. Yusuf, and B. Saez The Lkb1 metabolic sensor maintains haematopoietic stem cell survival Nature 468 7324 2010 659 663
18. D. Nakada, T.L. Saunders, and S.J. Morrison Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells Nature 468 7324 2010 653 658
19. A. Woods, S.R. Johnstone, K. Dickerson, F.C. Leiper, L.G. Fryer, and D. Neumann LKB1 is the upstream kinase in the AMP-activated protein kinase cascade Curr Biol 13 2003 2004 2008
20. J.M. Lizcano, O. Goransson, R. Toth, M. Deak, N.A. Morrice, and J. Boudeau LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1 EMBO J 23 2004 833 843
21. D.G. Hardie AMP-activated protein kinase - an energy sensor that regulates all aspects of cell function Genes Dev 25 18 2011 1895 1908
22. M.M. Mihaylova, and R.J. Shaw The AMPK signalling pathway coordinates cell growth, autophagy and metabolism Nat Cell Biol 13 9 2011 1016 1023
23. Z.X. Xu, J. Liang, V. Haridas, A. Gaikwad, G.B. Mills, and J.U. Gutterman A plant triterpenoid induces tumor cell autophagy by activation of AMPK Cell Death Differ 14 2007 1948 1957
24. M. Jalving, J.A. Gietema, J.D. Lefrandt, S. de Jong, A.K. Reyners, and R.O. Gans Metformin: taking away the candy for cancer? Eur J Cancer 46 13 2010 2369 2380
25. A. Decensi, M. Puntoni, P. Goodwin, M. Cazzaniga, A. Gennari, and B. Bonanni Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis Cancer Prev Res (Phila) 3 11 2010 1451 1461
26. R.J. Shaw, K.A. Lamia, D. Vasquez, S.H. Koo, N. Bardeesy, and R.A. Depinho The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin Science 310 2005 1642 1646
27. R.J. Dowling, M. Zakikhani, I.G. Fantus, M. Pollak, and N. Sonenberg Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells Cancer Res 67 2007 10804 10812
28. P.J. Goodwin, J.A. Ligibel, and V. Stambolic Metformin in breast cancer: time for action J Clin Oncol 27 20 2009 3271 3273
29. I. Ben Sahra, Y. Le Marchand-Brustel, J.F. Tanti, and F. Bost Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther 9 5 2010 1092 1099
30. B. Martin-Castillo, A. Vazquez-Martin, C. Oliveras-Ferraros, and J.A. Menendez Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena Cell Cycle 9 6 2010 1057 1064
31. K. Kisfalvi, G. Eibl, J. Sinnett-Smith, and E. Rozengurt Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth Cancer Res 69 2009 6539 6545
32. I. Ben Sahra, K. Laurent, A. Loubat, S. Giorgetti-Peraldi, P. Colosetti, and P. Auberger The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level Oncogene 27 25 2008 3576 3586
33. X. He, F.J. Esteva, J. Ensor, G.N. Hortobagyi, M.H. Lee, and S.C. Yeung Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer Ann Oncol 2011 10.1093/annonc/mdr534
34. A. Vazquez-Martin, C. Oliveras-Ferraros, and J.A. Menendez The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells Cell Cycle 8 1 2009 88 96
35. B. Liu, Z. Fan, S.M. Edgerton, X.S. Deng, I.N. Alimova, and S.E. Lind Metformin induces unique biological and molecular responses in triple negative breast cancer cells Cell Cycle 8 13 2009 2031 2040
36. V.N. Anisimov, L.M. Berstein, P.A. Egormin, T.S. Piskunova, I.G. Popovich, and M.A. Zabezhinski Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice Exp Gerontol 40 8-9 2005 685 693
37. H.A. Hirsch, D. Iliopoulos, P.N. Tsichlis, and K. Struhl Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission Cancer Res 69 2009 7507 7511
38. R.M. Memmott, and P.A. Dennis LKB1 and mammalian target of rapamycin as predictive factors for the anticancer efficacy of metformin J Clin Oncol 27 34 2009 e226
39. S. Wang, H. Wang, B. Davis, J. Liang, R. Cui, and S.J. Chen PARP1 inhibitors attenuate AKT phosphorylation via the upregulation of PHLPP1 Biochem Biophys Res Commun 412 2011 379 384
40. Z.X. Xu, T. Ding, V. Haridas, F. Connolly, and J.U. Gutterman Avicin D, a plant triterpenoid, induces cell apoptosis by recruitment of Fas and downstream signaling molecules into lipid rafts PLoS One 4 12 2009 e8532
41. M.J. Birnbaum, and R.J. Shaw Genomics: drugs, diabetes and cancer Nature 470 7334 2011 338 339
42. S.A. Hawley, F.A. Ross, C. Chevtzoff, K.A. Green, A. Evans, and S. Fogarty Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation Cell Metab 11 6 2010 554 565
43. J. Liang, S.H. Shao, Z.X. Xu, B. Hennessy, Z. Ding, and M. Larrea The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis Nat Cell Biol 9 2007 218 224
44. A. Puissant, G. Robert, N. Fenouille, F. Luciano, J.P. Cassuto, and S. Raynaud Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation Cancer Res 70 3 2010 1042 1052
45. A. Takamura, M. Komatsu, T. Hara, A. Sakamoto, C. Kishi, and S. Waguri Autophagy-deficient mice develop multiple liver tumors Genes Dev 25 8 2011 795 800
46. S. Shimizu, T. Kanaseki, N. Mizushima, T. Mizuta, S. Arakawa-Kobayashi, and C.B. Thompson Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes Nat Cell Biol 6 12 2004 1221 1228
47. G. Kroemer, G. Mariño, and B. Levine Autophagy and the integrated stress response Mol Cell 40 2 2010 280 293
48. M. Pollak Metformin and other biguanides in oncology: advancing the research agenda Cancer Prev Res (Phila) 3 9 2010 1060 1065
49. C. Algire, L. Amrein, M. Bazile, S. David, M. Zakikhani, and M. Pollak Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo Oncogene 30 10 2011 1174 1182
50. S. Fogarty, and D.G. Hardie Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer Biochim Biophys Acta 1804 3 2010 581 591
51. R.M. Memmott, J.R. Mercado, C.R. Maier, S. Kawabata, S.D. Fox, and P.A. Dennis Metformin prevents tobacco carcinogen-induced lung tumorigenesis Cancer Prev Res (Phila) 3 9 2010 1066 1076
52. 2 +/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells Cell Metab 2 1 2005 21 33
53. S.A. Hawley, D.A. Pan, K.J. Mustard, L. Ross, J. Bain, and A.M. Edelman Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase Cell Metab 2 1 2005 9 19
54. 2 +/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases J Biol Chem 280 32 2005 29060 29066
55. S.P. Hong, M. Momcilovic, and M. Carlson Function of mammalian LKB1 and Ca2 +/calmodulin-dependent protein kinase kinase alpha as Snf1-activating kinases in yeast J Biol Chem 280 23 2005 21804 21809
56. G. Herrero-Martín, M. Hoyer-Hansen, C. García- García, C. Fumarola, T. Farkas, and A. López-Rivas TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells EMBO J 28 6 2009 677 685
57. M. Xie, D. Zhang, J.R. Dyck, Y. Li, H. Zhang, and M. Morishima A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway Proc Natl Acad Sci U S A 103 46 2006 17378 17383
58. J. Nafz, J. De-Castro Arce, V. Fleig, A. Patzelt, S. Mazurek, and F. Rösl Interference with energy metabolism by 5-aminoimidazole-4-carboxamide- 1-beta-d-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1 Biochem J 403 3 2007 501 510
59. Z. Lu, X. Hu, Y. Li, L. Zheng, Y. Zhou, and H. Jiang Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin J Biol Chem 279 34 2004 35664 35670
60. L. Zheng, H. Ding, Z. Lu, Y. Li, Y. Pan, and T. Ning E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6 Genes Cells 13 3 2008 285 294
61. J.M. Spangle, and K. Münger The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis J Virol 84 18 2010 9398 9407